Oracle Investment Management Inc. lowered its position in Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Free Report) by 18.3% during the 4th quarter, Holdings Channel reports. The firm owned 111,575 shares of the medical research company’s stock after selling 24,953 shares during the quarter. Accelerate Diagnostics comprises approximately 0.3% of Oracle Investment Management Inc.’s investment portfolio, making […]
Oracle Investment Management Inc. reduced its holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 3.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 535,558 shares of the biotechnology company’s stock after selling 19,964 shares during the period. […]
Oracle Investment Management Inc. trimmed its position in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 82.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 178,354 shares of the company’s stock after selling 816,226 shares during the quarter. GeneDx makes up 0.3% of […]
Staley Capital Advisers Inc. lifted its stake in Forian Inc. (NASDAQ:FORA – Free Report) by 0.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,108,003 shares of the company’s stock after purchasing an additional 8,003 shares during the period. Staley Capital Advisers Inc. […]
AIGH Capital Management LLC trimmed its position in Biodesix, Inc. (NASDAQ:BDSX – Free Report) by 5.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,658,946 shares of the company’s stock after selling 247,752 shares during the quarter. Biodesix comprises approximately 3.4% of […]